Adherence clubs linked to 30% reduction in high viral load among postpartum South African women living with HIV
New mothers with HIV gain more weight on dolutegravir than efavirenz
SEARCH study finds universal 'test and treat' reduces infant HIV
Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women
Babies of South African mothers taking HIV therapy have worse health in early months – unless they are vaccinated and consistently breastfed
PrEP in pregnancy: safe, but many unanswered questions
Women with HIV not at higher risk of blood pressure disorders in pregnancy
Dolutegravir safety in pregnancy: risk is lower than first reported
Antiretrovirals do not cause neurodevelopmental harm to uninfected infants
